Hims Weight Loss Reviews 2026: Pricing & Verdict

Sources: Hims.com drug pricing page, Novo Nordisk press release, FormBlends cost analysis. Prices verified March 2026.

The Wegovy pill at $149 per month for lower doses (1.5 mg and 4 mg) represents a new entry point. Starting September 2026, the 4 mg dose increases to $199 per month. Novo Nordisk also offers multi-month subscription options with savings up to $1,200 per year on the injection and $600 per year on the pill.

Use our semaglutide dosage calculator to determine which dose level you will likely need based on your starting weight and goals.

Every Hims weight loss patient pays a separate membership fee: $39 for the first month, then $149 per month on auto-renewal. This membership covers:

• 24/7 provider messaging
• Dose adjustment consultations
• Educational content and tracking tools
• Ongoing clinical oversight

The membership does not include or guarantee a prescription. You pay $39 to access the platform even if the provider determines you are not a candidate for GLP-1 treatment.

The membership fee adds $1,788 per year to every plan. A patient who sees "$149/month" in an ad actually pays $298 per month minimum. This gap between advertised and actual cost is the single most common complaint in Hims weight loss reviews. For broader pricing context across the market, see how much is semaglutide.

Hims now offers multiple doses of both injectable and oral Wegovy (semaglutide), plus injectable Ozempic. These are manufactured by Novo Nordisk, FDA-approved, and identical to what you would receive at a retail pharmacy.

Wegovy is specifically approved for chronic weight management. Ozempic is FDA-approved for type 2 diabetes but commonly prescribed off-label for weight loss. Both contain the same active ingredient: semaglutide. Clinical trials show average weight loss of 15% of body weight over 68 weeks on the 2.4 mg maintenance dose.

The Wegovy pill is a newer formulation. It delivers semaglutide orally rather than by injection. Clinical data shows slightly less weight loss with oral versus injectable semaglutide (approximately 16.6% versus 20%+ body weight reduction), but the convenience factor matters for patients who refuse needles.

Hims still offers compounded semaglutide through partner pharmacies, though availability is shifting. The compounded injectable is priced at a flat $175 per month regardless of dose. Compounded oral semaglutide starts as low as $69 per month on a 10-month prepaid plan.

A critical regulatory note: Hims received an FDA warning letter in September 2025 specifically about its marketing of compounded semaglutide. The letter cited claims like "same active ingredient as Ozempic and Wegovy" and "clinically proven ingredients" as misleading. Hims then launched a $49 compounded semaglutide pill in early 2026, which was withdrawn under pressure from the FDA and a Novo Nordisk lawsuit.

The Novo Nordisk settlement effectively steers Hims toward branded products and away from compounding. Patients currently on compounded semaglutide through Hims should monitor for availability changes. For more on compounded formulations, see our compound semaglutide with B12 guide.

Hims does not prescribe tirzepatide (the active ingredient in Mounjaro and Zepbound). This is a meaningful limitation. Tirzepatide is a dual GIP/GLP-1 receptor agonist that produced up to 22.5% body weight loss in clinical trials, surpassing semaglutide's results. If you want tirzepatide, you need a different provider. See where to buy tirzepatide for current options.

Hims also does not offer retatrutide, survodutide, or other next-generation weight loss peptides still in clinical trials. The platform is focused exclusively on semaglutide-based treatments.

The Novo Nordisk partnership gives Hims something most telehealth competitors lack: direct access to branded Wegovy and Ozempic at negotiated prices. You receive the exact same medication manufactured by Novo Nordisk that you would get at CVS or Walgreens. No compounding variability. No potency questions. No sterility concerns from third-party pharmacies.

This is the single biggest improvement to the Hims weight loss platform in 2026. The branded supply chain eliminates the regulatory and quality risks that come with compounded GLP-1 medications. For patients concerned about semaglutide side effects, branded formulations provide more predictable dosing.

Hims is one of the few telehealth platforms offering both the Wegovy pill and Wegovy injection. Most competitors offer injections only. The oral option matters for the roughly 20% of patients who refuse self-injection entirely. If you are considering injections but feel nervous about the process, our how to inject peptides guide walks through the technique step by step.

Most patients report receiving medication within 5 to 7 days of completing the health questionnaire. Provider review typically happens within 24 hours. This timeline is competitive with the fastest telehealth platforms and dramatically faster than the 2 to 4 week waits common at brick-and-mortar clinics.

The Hims app is consistently praised in reviews. Medication tracking, provider messaging, educational content, and refill management are all integrated into a single interface. For a direct-to-consumer telehealth company, the user experience is best-in-class. The app design reduces the friction that causes patients to abandon treatment early.

Hims operates on a cash-pay model. You do not need insurance approval, prior authorization, or step therapy. For the millions of Americans whose insurance does not cover GLP-1 medications for weight loss, this removes the biggest barrier to access. HSA and FSA cards are accepted. For patients who do have coverage, compare pricing with our guide on tirzepatide cost with insurance.

The $149 monthly membership fee is the most controversial element of the Hims weight loss program. When Hims advertises "GLP-1 medications starting at $149/month," that price does not include the membership. Your actual minimum cost is $298 per month ($149 medication + $149 membership). Over a year, the membership alone costs $1,788.

Several competitors (Ro, MEDVi, Henry Meds) charge no separate membership fee. Their medication prices include provider access and ongoing care. The Hims pricing structure makes direct price comparisons misleading unless you add the membership to every quoted figure.

Hims prioritizes speed and convenience over clinical depth. Lab work is rarely required. Check-ins are not scheduled at regular intervals. Provider interactions happen primarily through asynchronous messaging. For healthy patients with straightforward weight loss goals, this level of oversight is adequate. For patients with diabetes, cardiovascular risk factors, kidney disease, or a history of eating disorders, it is not.

If you need comprehensive metabolic monitoring, regular lab draws, and frequent provider consultations, platforms like Ro Body or Calibrate offer more robust clinical programs. Hims is optimized for medication access, not intensive medical management.

There is no self-service cancel button in the Hims app or website. Cancellation requires contacting customer support directly. Multiple Reddit users and Trustpilot reviewers report difficulty canceling, unexpected charges after requesting cancellation, and unclear timelines for when cancellation takes effect. This is the most common operational complaint across all Hims product lines, not just weight loss.

Hims does not offer tirzepatide in any form. Patients who plateau on semaglutide or who want the higher average weight loss associated with tirzepatide (22.5% vs. 15% body weight in clinical trials) must switch providers entirely. This limits Hims to a single drug pathway, which reduces flexibility as treatment progresses. Our guide on the best peptides for weight loss covers all available options.

The September 2025 FDA warning letter, the $49 pill withdrawal, the Novo Nordisk lawsuit, and the subsequent settlement paint a picture of a company that pushed marketing boundaries and got pulled back. The platform is now on firmer regulatory ground with branded medications, but the history matters. Patients should be aware that Hims has been cited for misleading claims about its compounded products.

Hims holds a 3.5 out of 5 rating across approximately 8,000 Trustpilot reviews as of March 2026. This rating covers all Hims products (hair loss, ED, mental health, weight loss), not just the weight loss program. Weight-loss-specific reviews skew slightly more positive, with users citing effective appetite suppression and convenient delivery.

The most common five-star review pattern: "Easy signup, medication arrived fast, lost X pounds in Y weeks." The most common one-star review pattern: "Charged after I tried to cancel" or "Can't reach anyone in customer support."

Reddit provides the most unfiltered feedback. Common themes from r/semaglutide and related communities:

Positive patterns: - "Lost 35 pounds in three months on the oral semaglutide. Appetite is genuinely suppressed." - "Medication arrived in 5 days. The app is actually useful for tracking." - "Switched from a local clinic to Hims. Paying half what I was paying before for the same drug."

Negative patterns: - "The $149 membership fee on top of medication cost is ridiculous. That's $1,788/year for text messaging." - "Tried to cancel for three weeks. They kept charging me. Had to dispute with my bank." - "Provider never actually talked to me. Just approved the prescription from my questionnaire." - "Nausea hit hard the first two weeks. No one from Hims checked in proactively."

The overall Reddit consensus: the medication works, the app is solid, but the billing practices and customer service create unnecessary frustration. Most dissatisfied users are angry about money, not medicine.

For managing the nausea that many users report, see our guide on semaglutide and nausea.

ConsumerAffairs reviews mirror the Reddit split. Positive reviews praise convenience and results. Negative reviews focus on billing disputes and cancellation difficulties. The BBB profile shows a pattern of complaints about unauthorized charges and slow refund processing. Hims is not BBB-accredited.

A recurring theme across all platforms: Hims responds to negative reviews publicly but resolution timelines vary. Some users report quick fixes once they escalate. Others describe weeks of back-and-forth without resolution.

The FDA issued a warning letter to both Hims and Hers on September 9, 2025, citing misleading marketing of compounded semaglutide. Specific violations included claims that compounded products contained the "same active ingredient" as FDA-approved drugs and use of "clinically proven" language. The FDA's position: compounded drugs are not FDA-approved, are not tested for bioequivalence, and should not be marketed as equivalent to branded products.

This warning letter was part of a broader enforcement action. The FDA sent over 55 warning letters to online sellers of compounded GLP-1 medications in September 2025. The agency specifically targeted direct-to-consumer advertising and marketing practices.

In early 2026, Novo Nordisk sued Hims over its $49 compounded semaglutide pill, alleging patent infringement. Hims withdrew the product. The two companies then reached a settlement in March 2026 under which Hims became an authorized distributor of branded Novo Nordisk products (Wegovy, Ozempic) and agreed to shift away from marketing compounded GLP-1 medications.

This settlement fundamentally changed the Hims weight loss business model. The company now operates as a distribution channel for Novo Nordisk rather than a compounding-focused telehealth platform.

The shift to branded medications is a net positive for patient safety. Branded Wegovy and Ozempic are FDA-approved, manufactured under strict quality controls, and supported by extensive clinical trial data. The potency, sterility, and formulation concerns that apply to compounded products do not apply here.

The trade-off is cost. Branded medications through Hims cost more than compounded alternatives from other platforms. Patients who prioritized Hims for its low compounded semaglutide pricing may find better value elsewhere. For a comprehensive look at all pricing options, see how much is semaglutide.